https://www.clinicaltrialsarena.com/news/neurana-enrols-first-patient/
Neurana Pharmaceuticals has enrolled the first patient in the Phase ll Study evaluating tolperisone for the treatment of acute muscle spasms of the back.
firstpatientphasetrialtolperisone